Institutional investors hold a majority ownership of MRK through the 75.50% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended June 2019, these large investors purchased a net $3.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORDEA INVESTMENT MANAGEMENT AB Bought 745.2 Thousand shares of Merck & Co Inc
DJE KAPITAL AG Bought 246.6 Thousand shares of Merck & Co Inc
HSBC GLOBAL ASSET MANAGEMENT (HO... Bought 175.7 Thousand shares of Merck & Co Inc